IBRANCE

Pfizer Announces IBRANCE Clinical Trials Ended Early In Light of Promising News

Medicine & Technology Apr 16, 2015

In light of promising results conducted by an independent data monitoring committee, Pfizer’s newest treatment IBRANCE (Palbociclib) ended clinical trials early this week as phase 3 of the trials ended demonstrating improvement in progression-free survival in women who had undergone treatment for metastatic breast cancer.

Most Popular

How Technology Is Changing the Real Estate Industry?

How a Plant-Based Diet Can Protect Against Breast Cancer: Insights from Nutrition Research

How a Plant-Based Diet Can Protect Against Breast Cancer: Insights from Nutrition Research

Study Reveals High Turnover in Scientific Research Careers: What This Means for Future Scientists

Why It's So Difficult to Lose Weight: The Biological Explanation Behind Obesity

Nikolay Karpenko – Founder of Herculis Group

Nikolay Karpenko Biography, Photo, Career, Accomplishments

Recommended Stories

NASA Shuts Down Voyager 2 Science Instrument After 47 Years to Conserve Power

SPACE

NASA Shuts Down Voyager 2 Science Instrument After 47 Years to Conserve Energy

OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find “Hallucinated” Text in Transcripts

TECH & INNOVATION

OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts

Martian Ice May Support Microbial Life Beneath Its Surface, New Study Suggests

SPACE

Martian Ice May Support Microbial Life Beneath Its Surface, New Study Suggests

NASA Astronaut Hospitalized After Returning from Extended Space Mission

SPACE

NASA Astronaut Hospitalized After Returning from Extended Space Mission